Waverley Pharma, Inc. (WAVE.V)
0.01
0.00 (0.00%)
CAD |
TSXV |
Oct 13, 16:00
Waverley Pharma Net Income (Quarterly) : -0.1437M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1437M |
| March 31, 2026 | -0.1655M |
| December 31, 2025 | -0.1973M |
| September 30, 2025 | -0.238M |
| June 30, 2025 | -0.0278M |
| March 31, 2025 | -0.0361M |
| December 31, 2024 | -0.0652M |
| September 30, 2024 | -0.2729M |
| June 30, 2024 | -0.3448M |
| March 31, 2024 | -0.2641M |
| December 31, 2023 | -1.334M |
| September 30, 2023 | -0.31M |
| June 30, 2023 | -0.241M |
| March 31, 2023 | -0.3396M |
| December 31, 2022 | -0.2073M |
| September 30, 2022 | -0.1217M |
| June 30, 2022 | -0.024M |
| March 31, 2022 | -0.311M |
| December 31, 2021 | -0.268M |
| Date | Value |
|---|---|
| September 30, 2021 | -0.2072M |
| June 30, 2021 | -0.1474M |
| March 31, 2021 | -0.1739M |
| December 31, 2020 | -0.3222M |
| September 30, 2020 | 0.001M |
| June 30, 2020 | -0.2021M |
| March 31, 2020 | -0.1825M |
| December 31, 2019 | -0.3576M |
| September 30, 2019 | -0.4803M |
| June 30, 2019 | -0.2302M |
| March 31, 2019 | -0.1721M |
| December 31, 2018 | -0.25M |
| September 30, 2018 | -0.2121M |
| June 30, 2018 | -0.6109M |
| March 31, 2018 | -0.3476M |
| December 31, 2017 | -2.336M |
| September 30, 2017 | -0.0136M |
| June 30, 2017 | -0.015M |
| March 31, 2017 | -0.0001M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Kane Biotech, Inc. | -0.8336M |
| Quest PharmaTech, Inc. | 3.401M |
| BriaCell Therapeutics Corp. | -9.920M |
| Vaxil Bio Ltd. | -0.064M |
| Goldcoast Resource Corp. | -0.0999M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.3145M |
| Total Expenses (Quarterly) | 0.4581M |
| EPS Diluted (Quarterly) | -0.0027 |
| Enterprise Value | 4.099M |
| Gross Profit Margin (Quarterly) | 29.06% |
| Profit Margin (Quarterly) | -45.69% |
| Earnings Yield | -138.0% |
| Normalized Earnings Yield | -138.00 |